C
CytoTools AG
XETRA:T5O
CytoTools AG
XETRA:T5O
Price:
101.26
EUR
0.98%
Market Closed
Market Cap:
€1.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CytoTools AG
XETRA:T5O
|
DE |
|
N
|
Nutrien Ltd
NYSE:NTR
|
CA |
Balance Sheet
Balance Sheet Decomposition
CytoTools AG
CytoTools AG
Balance Sheet Decomposition is not available for
CytoTools AG
CytoTools AG
Balance Sheet
CytoTools AG
CytoTools AG
Currency: EUR
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
1
|
3
|
1
|
2
|
3
|
2
|
2
|
0
|
2
|
|
| Cash Equivalents |
2
|
1
|
3
|
1
|
2
|
3
|
2
|
2
|
0
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
1
|
3
|
1
|
2
|
3
|
2
|
2
|
0
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
8
|
8
|
8
|
8
|
10
|
13
|
16
|
21
|
18
|
20
|
|
| Total Assets |
10
N/A
|
9
-14%
|
11
+24%
|
10
-8%
|
13
+23%
|
16
+31%
|
18
+9%
|
22
+25%
|
18
-18%
|
22
+18%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
0
-86%
|
0
-70%
|
0
+30%
|
2
+1 514%
|
3
+46%
|
0
-96%
|
0
+234%
|
0
+8%
|
0
-53%
|
|
| Equity | |||||||||||
| Common Stock |
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
5
|
|
| Retained Earnings |
6
|
7
|
9
|
11
|
12
|
13
|
17
|
17
|
21
|
21
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
19
|
20
|
24
|
31
|
34
|
34
|
38
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
9
+5%
|
11
+27%
|
10
-8%
|
11
+5%
|
14
+28%
|
18
+31%
|
22
+24%
|
18
-19%
|
21
+20%
|
|
| Total Liabilities & Equity |
10
N/A
|
9
-14%
|
11
+24%
|
10
-8%
|
13
+23%
|
16
+31%
|
18
+9%
|
22
+25%
|
18
-18%
|
22
+18%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
